Jeffrey S. Parkin

Array ( [id] => 9749418 [patent_doc_number] => 08840890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Rapid expression cloning of human monoclonal antibodies from memory B cells' [patent_app_type] => utility [patent_app_number] => 13/128837 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 26852 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 801 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6395435 [patent_doc_number] => 20100178290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'Methods for reducing viral load in HIV-1 infected patients' [patent_app_type] => utility [patent_app_number] => 12/590005 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 55748 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20100178290.pdf [firstpage_image] =>[orig_patent_app_number] => 12590005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6434187 [patent_doc_number] => 20100278853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'CONSTRAINED HIV V3 LOOP PEPTIDES AS NOVEL IMMUNOGENS AND RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/579938 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 43795 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278853.pdf [firstpage_image] =>[orig_patent_app_number] => 12579938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8293981 [patent_doc_number] => 08221768 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence' [patent_app_type] => utility [patent_app_number] => 12/580080 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32194 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12580080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4455311 [patent_doc_number] => 07892562 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Methods of inducing TH-1 immune responses to HIV-1 by administering UV/psoralen-treated desialated inactiviated HIV-1 virions deficient in CD55 and CD59' [patent_app_type] => utility [patent_app_number] => 12/576055 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10713 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892562.pdf [firstpage_image] =>[orig_patent_app_number] => 12576055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356231 [patent_doc_number] => 20100086956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'DETECTION OF HIV-RELATED PROTEINS IN URINE' [patent_app_type] => utility [patent_app_number] => 12/572652 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6396 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086956.pdf [firstpage_image] =>[orig_patent_app_number] => 12572652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6579739 [patent_doc_number] => 20100273996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Method' [patent_app_type] => utility [patent_app_number] => 12/587236 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 24443 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273996.pdf [firstpage_image] =>[orig_patent_app_number] => 12587236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164942 [patent_doc_number] => 20110195083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'CYCLIC V3 PEPTIDES FOR ANTI HIV-1 VACCINE' [patent_app_type] => utility [patent_app_number] => 13/122972 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 34474 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195083.pdf [firstpage_image] =>[orig_patent_app_number] => 13122972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9019926 [patent_doc_number] => 08529909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Method for the production and purification of bovine leukemia virus GP51 surface glycoprotein in the absence of bovine serum' [patent_app_type] => utility [patent_app_number] => 13/059568 [patent_app_country] => US [patent_app_date] => 2009-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 817 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097401 [patent_doc_number] => 20110003735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'PEPTIDE DERIVATIVE FUSION INHIBITORS OF HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 12/567250 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14191 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003735.pdf [firstpage_image] =>[orig_patent_app_number] => 12567250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097401 [patent_doc_number] => 20110003735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'PEPTIDE DERIVATIVE FUSION INHIBITORS OF HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 12/567250 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14191 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003735.pdf [firstpage_image] =>[orig_patent_app_number] => 12567250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6606756 [patent_doc_number] => 20100099079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Non-dividing cell-based assay for high throughput antiviral compound screening' [patent_app_type] => utility [patent_app_number] => 12/566074 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11197 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099079.pdf [firstpage_image] =>[orig_patent_app_number] => 12566074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487395 [patent_doc_number] => 20110236373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Method of detecting antibodies and antibody-hiv virion complexes' [patent_app_type] => utility [patent_app_number] => 12/998211 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 14173 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236373.pdf [firstpage_image] =>[orig_patent_app_number] => 12998211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187871 [patent_doc_number] => 20110171250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Synthetic Gene Construct Coding for an HIV1 GAG and Use Thereof for Obtaining Anti-HIV-1 Vaccines' [patent_app_type] => utility [patent_app_number] => 13/063277 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3969 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171250.pdf [firstpage_image] =>[orig_patent_app_number] => 13063277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656480 [patent_doc_number] => 20110305749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'HIV-1 Envelope Polypeptides for HIV Vaccine' [patent_app_type] => utility [patent_app_number] => 13/060564 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 52962 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305749.pdf [firstpage_image] =>[orig_patent_app_number] => 13060564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033051 [patent_doc_number] => 20110082075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Anti-viral fusion peptides' [patent_app_type] => utility [patent_app_number] => 12/583780 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18734 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082075.pdf [firstpage_image] =>[orig_patent_app_number] => 12583780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197140 [patent_doc_number] => 20120121631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'POLYVALENT VACCINE' [patent_app_type] => utility [patent_app_number] => 12/737761 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 109 [patent_figures_cnt] => 109 [patent_no_of_words] => 13262 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12737761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4497508 [patent_doc_number] => 07919101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors' [patent_app_type] => utility [patent_app_number] => 12/540325 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 13453 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919101.pdf [firstpage_image] =>[orig_patent_app_number] => 12540325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317602 [patent_doc_number] => 08232379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence' [patent_app_type] => utility [patent_app_number] => 12/508946 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21460 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12508946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490422 [patent_doc_number] => 20090291493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'HUMAN IMMUNODEFICIENCY VIRUS-NEUTRALIZING ANTIBODIES WITH IMPROVED BREADTH AND POTENCY' [patent_app_type] => utility [patent_app_number] => 12/508913 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12828 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291493.pdf [firstpage_image] =>[orig_patent_app_number] => 12508913 [rel_patent_id] =>[rel_patent_doc_number] =>)